STOCK TITAN
  1. Home
  2. Sec-filings
  3. HBIO
  4. [EFFECT] HARVARD BIOSCIENCE INC SEC Filing

[EFFECT] HARVARD BIOSCIENCE INC SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 9, 2026 10:00 A.M.
Form: S-3
CIK: 0001123494
Company Name: HARVARD BIOSCIENCE INC
File Number: 333-293099

Source: View Original Filing on SEC EDGAR

Harvard Biosci

NASDAQ:HBIO

View HBIO Stock Overview →

HBIO Rankings

#6068 Ranked by Market Cap
N/A Ranked by Dividends

HBIO Latest News

Mar 12, 2026
Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results
Mar 6, 2026
Harvard Bioscience Announces Reverse Stock Split
Mar 3, 2026
Harvard Bioscience to Participate in KeyBanc’s Virtual Healthcare Forum
Feb 26, 2026
Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET
Feb 10, 2026
Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas

HBIO Latest SEC Filings

Apr 1, 2026
[Form 4] HARVARD BIOSCIENCE INC Insider Trading Activity
Apr 1, 2026
[Form 4] HARVARD BIOSCIENCE INC Insider Trading Activity
Mar 23, 2026
[Form 4] HARVARD BIOSCIENCE INC Insider Trading Activity
Mar 23, 2026
[SCHEDULE 13D] HARVARD BIOSCIENCE INC Major Shareholder Acquisition (>5%)
Mar 18, 2026
[Form 4] HARVARD BIOSCIENCE INC Insider Trading Activity

HBIO Stock Data

23.25M
3.98M
Medical Instruments & Supplies
Laboratory Analytical Instruments
Link
United States
HOLLISTON